- Home
- KPLT vs NTRB Comparison
KPLT vs NTRB Comparison
Compare KPLT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPLT | NTRB |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 71.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KPLT | NTRB |
|---|---|---|
| Price | $6.96 | $5.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.1M | 19.6K |
| Earning Date | 11-12-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $280,839,000.00 | $2,278,321.00 |
| Revenue This Year | $21.42 | $30.17 |
| Revenue Next Year | $15.48 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.15 | 12.69 |
| 52 Week Low | $5.08 | $3.72 |
| 52 Week High | $24.34 | $11.78 |
Technical Indicators
Market Signals| Indicator | KPLT | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 49.93 | 58.64 |
| Support Level | $6.24 | $4.34 |
| Resistance Level | $6.80 | $4.77 |
| Average True Range (ATR) | 0.57 | 0.45 |
| MACD | 0.22 | 0.11 |
| Stochastic Oscillator | 29.51 | 51.93 |
Price Performance
Historical ComparisonAbout KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.